Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sarissa Capital
Pharma
Investor group calls for strategy shift at struggling Amarin
Two "concerned shareholders" are calling for an immediate strategic review at Amarin just two years after the company faced another investor activism.
Zoey Becker
Mar 20, 2025 11:00am
Amarin's CEO resigns, leaving former interim chief to take over
Jun 4, 2024 11:19am
Amarin axes 120 of its 385 employees, hires new CEO Patrick Holt
Jul 19, 2023 10:45am
Alkermes shareholders reject 3 board nominees from Sarissa
Jun 30, 2023 10:50am
Sarissa Capital fights for spots on Alkermes' board
Jun 12, 2023 9:45am
Amarin names new interim CEO and board member
Apr 17, 2023 1:52pm
